MAP3K7 Antibody (S192) Blocking Peptide

MAP3K7 Antibody (S192) Blocking Peptide

€363.00
In stock
SKU
AC-BP7953e
Catalog Number: AC-BP7953e
Size: 500 µg
Datasheet
Request Information
Background:
TAK1 is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses.

Other Names:
Mitogen-activated protein kinase kinase kinase 7, Transforming growth factor-beta-activated kinase 1, TGF-beta-activated kinase 1, MAP3K7, TAK1

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7953e was selected from the S192 region of human MAP3K7. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: MAP3K7 {ECO:0000303|PubMed:28397838, ECO:0000312|HGNC:HGNC:6859}

Gene ID: 6885
Primary Accession: O43318
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:MAP3K7 Antibody (S192) Blocking Peptide